FBLGFibroBiologics, Inc.

Nasdaq fibrobiologics.com


$ 2.06 $ 0.23 (12.37 %)    

Friday, 06-Sep-2024 15:58:09 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 2.09
$ 2.09 x 100
$ 2.14 x 211
-- - --
$ 1.08 - $ 55.00
501,200
na
73.48M
$ -2.96
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

EF Hutton analyst Jason Kolbert initiates coverage on FibroBiologics (NASDAQ:FBLG) with a Buy rating and announces Price Tar...

Core News & Articles

FibroBiologics, Inc. - Common Stock (NASDAQ:FBLG) reported quarterly earnings of $0.03 per share which beat the analyst consens...

Core News & Articles

- SEC Filing

Core News & Articles

Company Holds 150+ Patents For Fibroblast-Based Therapeutics And Cures For Chronic Diseases

Core News & Articles

- SEC Filing

Core News & Articles

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of Fib...

Core News & Articles

FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued ...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION